Cargando…
Comparative analysis on the anti-inflammatory/immune effect of mesenchymal stem cell therapy for the treatment of pulmonary arterial hypertension
Despite the advancement of targeted therapy for pulmonary arterial hypertension (PAH), poor prognosis remains a reality. Mesenchymal stem cells (MSCs) are one of the most clinically feasible alternative treatment options. We compared the treatment effects of adipose tissue (AD)-, bone marrow (BD)-,...
Autores principales: | Oh, Seyeon, Jang, Albert Y., Chae, Sehyun, Choi, Seungbum, Moon, Jeongsik, Kim, Minsu, Spiekerkoetter, Edda, Zamanian, Roham T., Yang, Phillip C., Hwang, Daehee, Byun, Kyunghee, Chung, Wook-Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820276/ https://www.ncbi.nlm.nih.gov/pubmed/33479312 http://dx.doi.org/10.1038/s41598-021-81244-1 |
Ejemplares similares
-
Stem Cell and Exosome Therapy in Pulmonary Hypertension
por: Oh, Seyeon, et al.
Publicado: (2022) -
A case of recurrent pericardial constriction presenting with severe pulmonary hypertension
por: Brunner, Nathan W., et al.
Publicado: (2013) -
Pyrogallol-Phloroglucinol-6 6-Bieckol on Attenuates High-Fat Diet-Induced Hypertension by Modulating Endothelial-to-Mesenchymal Transition in the Aorta of Mice
por: Son, Myeongjoo, et al.
Publicado: (2021) -
Exome data clouds the pathogenicity of genetic variants in Pulmonary Arterial Hypertension
por: Abbasi, Yeganeh, et al.
Publicado: (2018) -
Attenuating Effects of Dieckol on Hypertensive Nephropathy in Spontaneously Hypertensive Rats
por: Son, Myeongjoo, et al.
Publicado: (2021)